Black and White Patients With Staphylococcus aureus Bacteremia Have Similar Outcomes but Different Risk Factors
- PMID: 36373405
- PMCID: PMC10319766
- DOI: 10.1093/cid/ciac893
Black and White Patients With Staphylococcus aureus Bacteremia Have Similar Outcomes but Different Risk Factors
Abstract
Background: Staphylococcus aureus bacteremia (SAB) disproportionately affects Black patients. The reasons for this disparity are unclear.
Methods: We evaluated a prospectively ascertained cohort of patients with SAB from 1995 to 2020. Clinical characteristics, bacterial genotypes, and outcome were compared among Black and White patients with SAB. Multivariable logistic regression models were used to determine factors independently associated with the outcomes.
Results: Among 3068 patients with SAB, 1107 (36%) were Black. Black patients were younger (median, 56 years vs 63 years; P < .001) and had higher rates of diabetes (47.5% vs 34.5%, P < .001), hemodialysis dependence (40.0% vs 7.3%, P < .001), and human immunodeficiency virus (6.4% vs 0.6%, P < .001). Black patients had higher rates of methicillin-resistant S. aureus (49.3% vs 44.9%, P = .020), including the USA300 hypervirulent clone (11.5% vs 8.4%, P = .007). White patients had higher rates of corticosteroid use (22.4% vs 15.8%, P < .0001) and surgery in the preceding 30 days (28.1% vs 18.7%, P < .001). Although the median Acute Physiology Score (APS) at the time of initial SAB diagnosis was significantly higher in Black patients (median APS, 9; interquartile range [IQR], 5-14 vs median APS, 7; IQR, 4-12; P < .001), race was not associated with 90-day mortality (risk ratio, 1.02; 95% confidence interval, .93-1.12), and rates of metastatic infection were lower among Black patients (37.2% vs 41.3% White, P = .029).
Conclusions: Despite differences in Black patients' higher APS on presentation and more risk factors, including a 5 times higher risk of hemodialysis dependence, 90-day mortality among Black and White patients with SAB was similar.
Keywords: Staphylococcus aureus bacteremia; bacterial genotype; hemodialysis; mortality; racial disparities.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. V. G. F. reports personal consulting fees from Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co, MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny, Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio, Akagera, Aridis, Roche, and Pfizer; grants from NIH, MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck, Medical Biosurfaces, Locus, Affinergy, Contrafect, Karius, Genentech, Regeneron, Deep Blue, Basilea, Janssen; royalties from UpToDate; stock options from Valanbio and ArcBio; honoraria from the Infectious Diseases Society of America for service as associate editor of Clinical Infectious Diseases (2017–2022); a patent on sepsis diagnostics pending; and support from Contrafect to present phase 2 data at 2019 European Congress of Clinical Microbiology & Infectious Diseases. All remaining authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Figures


Similar articles
-
A Prospective Cohort Study of Durations of Staphylococcus aureus Bacteremia According to Different Phenotypes and a New Concept of Persistent Bacteremia.Antimicrob Agents Chemother. 2019 Dec 20;64(1):e01656-19. doi: 10.1128/AAC.01656-19. Print 2019 Dec 20. Antimicrob Agents Chemother. 2019. PMID: 31636069 Free PMC article.
-
Staphylococcus aureus Bacteremia Among Patients Receiving Maintenance Hemodialysis: Trends in Clinical Characteristics and Outcomes.Am J Kidney Dis. 2022 Mar;79(3):393-403.e1. doi: 10.1053/j.ajkd.2021.06.018. Epub 2021 Jul 23. Am J Kidney Dis. 2022. PMID: 34303771 Free PMC article.
-
Risk Factors for Recurrent Staphylococcus aureus Bacteremia.Clin Infect Dis. 2021 Jun 1;72(11):1891-1899. doi: 10.1093/cid/ciaa801. Clin Infect Dis. 2021. PMID: 32564065 Free PMC article.
-
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.Scand J Infect Dis. 2009;41(1):4-9. doi: 10.1080/00365540802441711. Scand J Infect Dis. 2009. PMID: 18821135
-
Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis.Korean J Intern Med. 2019 Nov;34(6):1347-1362. doi: 10.3904/kjim.2017.098. Epub 2018 Jan 20. Korean J Intern Med. 2019. PMID: 29347812 Free PMC article.
Cited by
-
The association of female sex with management and mortality in patients with Staphylococcus aureus bacteraemia.Clin Microbiol Infect. 2023 Sep;29(9):1182-1187. doi: 10.1016/j.cmi.2023.06.009. Epub 2023 Jun 14. Clin Microbiol Infect. 2023. PMID: 37321394 Free PMC article.
-
Quantifying Health Outcome Disparity in Invasive Methicillin-Resistant Staphylococcus aureus Infection using Fairness Algorithms on Real-World Data.Pac Symp Biocomput. 2024;29:419-432. Pac Symp Biocomput. 2024. PMID: 38160296 Free PMC article.
-
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA).Antibiotics (Basel). 2023 Apr 12;12(4):742. doi: 10.3390/antibiotics12040742. Antibiotics (Basel). 2023. PMID: 37107104 Free PMC article. Review.
References
-
- Inagaki K, Lucar J, Blackshear C, Hobbs CV. Methicillin-susceptible and methicillin-resistant Staphylococcus aureus bacteremia: nationwide estimates of 30-day readmission, in-hospital mortality, length of stay, and cost in the United States. Clin Infect Dis 2019; 69:2112–8. - PubMed
-
- Bader MS, Kempker RR, Farley MM, Ladson JL, Satola S, Ray SM. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain. Infect Control Hosp Epidemiol 2006; 27:1219–25. - PubMed
-
- Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000; 31:1170–4. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous